mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-06 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.91 |
5e-05 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |